MUCOSAL PROLAPSE SYNDROME

This adverse event was reported 27 times

MUCOSAL PROLAPSE SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEPOTASTINE BESILATE 1 0.0016
1 SOYBEAN OIL 1 0.0015
2 METRELEPTIN 1 0.0008
3 PSYLLIUM HUSK 1 0.0007
4 LEVALBUTEROL HYDROCHLORIDE 1 0.0003
5 LEVOCARNITINE 1 0.0003
6 DESMOPRESSIN ACETATE 1 0.0003
7 TRIAZOLAM 1 0.0002
8 PAROXETINE HYDROCHLORIDE 6 0.0001
9 PAROXETINE HYDROCHLORIDE HEMIHYDRATE 4 0.0001
See all drugs enriched for association with MUCOSAL PROLAPSE SYNDROME

MUCOSAL PROLAPSE SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Leptin Analog [EPC] 1 0.0008
1 Lipid Emulsion [EPC] 1 0.0004
2 Carnitine Analog [EPC] 1 0.0003
3 Antifibrinolytic Agent [EPC] 1 0.0001
4 GLP-2 Analog [EPC] 1 0.0001
5 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
6 Stimulant Laxative [EPC] 1 0.0001
7 Provitamin D2 Compound [EPC] 2 0.0001
8 Aluminum Complex [EPC] 1 0.0000
9 Aminoglycoside Antibacterial [EPC] 1 0.0000
See all drug classes enriched for association with MUCOSAL PROLAPSE SYNDROME